| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.00 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.01 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.00 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.01 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cancer stem cells |
Salisphere assay |
0.01 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cancer stem cells |
Salisphere assay |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cancer stem cells |
Salisphere assay |
1.00 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
